Targeted Drugs for Metastatic Renal Cell Carcinoma
Metastatic renal cell carcinoma had been considered a cancer with a poor prognosis.
Originally published on 12/22/2007 in The Lancet
Drs. Robert J Motzer and Ethan Basch compare the costs, efficacy, and patient experience of targeted therapies for metastatic renal cell carcinoma.
Read the full article here.